Switch from indinavir to ritonavir-indinavir regimen in patients treated with highly active antiretroviral therapy co-infected with hepatitis C is not associated with alteration of liver function tests

被引：11

作者：

Vora, S ^{[1
]}

Michon, C ^{[1
]}

Junet, C ^{[1
]}

Balavoine, JF ^{[1
]}

Renold-Moynier, C ^{[1
]}

Yerly, S ^{[1
]}

Perrin, L ^{[1
]}

机构：

[1] Univ Hosp Geneva, Div Infect Dis, Virol Lab, CH-1211 Geneva 14, Switzerland

来源：

AIDS | 2000年 / 14卷 / 17期

关键词：

D O I：

10.1097/00002030-200012010-00024

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：2795 / 2797

页数：3

共 9 条

[1]

Arribas JR, 1998, AIDS, V12, P1722

[2] Changes in renal function associated with indinavir [J].

Boubaker, K ;

Sudre, P ;

Bally, F ;

Vogel, G ;

Meuwly, JY ;

Glauser, MP ;

Telenti, A .

AIDS, 1998, 12 (18) :F249-F254

[3] Nephropathy and renal colic in patients treated with indinavir, ritonavir plus indinavir or ritonavir plus saquinavir [J].

Padberg, J ;

Fritsche, L ;

Bergmann, F ;

Schürmann, D ;

Suttorp, N .

AIDS, 1999, 13 (15) :2173-2174

[4] Hepatotoxicity after introduction of highly active antiretroviral therapy [J].

Rodríguez-Rosado, R ;

García-Samaniego, J ;

Soriano, V .

AIDS, 1998, 12 (10) :1256-1256

[5] Discontinuation rates for protease inhibitor regimens containing ritonavir 600 mg versus ritonavir 400 mg plus saquinavir 400 mg [J].

Rublein, JC ;

Eron, JJ ;

Butts, JD ;

Raasch, RH .

ANNALS OF PHARMACOTHERAPY, 1999, 33 (09) :899-905

[6] Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus [J].

Sulkowski, MS ;

Mast, EE ;

Seeff, LB ;

Thomas, DL .

CLINICAL INFECTIOUS DISEASES, 2000, 30 :S77-S84

[7] Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection [J].

Sulkowski, MS ;

Thomas, DL ;

Chaisson, RE ;

Moore, RD .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (01) :74-80

[8] The steady-state plasma pharmacokinetics of indinavir alone and in combination with a low dose of ritonavir in twice daily dosing regimens in HIV-1-infected individuals [J].

van Heeswijk, RPG ;

Veldkamp, AI ;

Hoetelmans, RMW ;

Mulder, JW ;

Schreij, G ;

Hsu, A ;

Lange, JMA ;

Beijnen, JH ;

Meenhorst, PL .

AIDS, 1999, 13 (14) :F95-F99

[9]

Vento S, 1998, AIDS, V12, P116

← 1 →